RNF213 gene silencing upregulates transforming growth factor β1 expression in bone marrow-derived mesenchymal stem cells and is involved in the onset of Moyamoya disease.
- DOI
- 10.3892/etm.2021.10456
- Published
- 2021 Sep
- Container
- Experimental and therapeutic medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3892/etm.2021.10456,
title = {RNF213 gene silencing upregulates transforming growth factor β1 expression in bone marrow-derived mesenchymal stem cells and is involved in the onset of Moyamoya disease.},
author = {Wang C and Sun C and Zhao Y and Song H and Li Z and Jin F and Cui C},
year = {2021},
journal = {Experimental and therapeutic medicine},
doi = {10.3892/etm.2021.10456},
url = {https://doi.org/10.3892/etm.2021.10456}
}RIS
TY - JOUR TI - RNF213 gene silencing upregulates transforming growth factor β1 expression in bone marrow-derived mesenchymal stem cells and is involved in the onset of Moyamoya disease. AU - Wang C AU - Sun C AU - Zhao Y AU - Song H AU - Li Z AU - Jin F AU - Cui C PY - 2021 JO - Experimental and therapeutic medicine DO - 10.3892/etm.2021.10456 UR - https://doi.org/10.3892/etm.2021.10456 ER -
APA
C, W., C, S., Y, Z., H, S., Z, L., F, J., & C, C. (2021). RNF213 gene silencing upregulates transforming growth factor β1 expression in bone marrow-derived mesenchymal stem cells and is involved in the onset of Moyamoya disease.. Experimental and therapeutic medicine. https://doi.org/10.3892/etm.2021.10456
Source records
- pubmed · retrieved 2026-09-25T23:28:52.020Z